Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. | PLoS One | 2024 | 38968186 | PubTator, text mining | PubMed |
| Association of early menarche with breast tumor molecular features and recurrence. | Breast Cancer Res | 2024 | 38886818 | PubTator, text mining | PubMed |
| Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Gastroenterol Hepatol | 2024 | 38723644 | PubTator, text mining | PubMed |
| Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients. | Breast Cancer Res Treat | 2024 | 38709373 | PubTator, text mining | PubMed |
| A Rare Case of Benign Recurrent Intrahepatic Cholestasis Initially Diagnosed in Middle-age. | Altern Ther Health Med | 2024 | 38607191 | PubTator, text mining | PubMed |
| A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies. | EBioMedicine | 2024 | 38447275 | PubTator, text mining | PubMed |
| The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function. | J Crohns Colitis | 2024 | 38366839 | PubTator, text mining | PubMed |
| Exceptional Liver Transplant Indications: Unveiling the Uncommon Landscape. | Diagnostics (Basel) | 2024 | 38275473 | PubTator, text mining | PubMed |
| Nucleoid-associated proteins shape the global protein occupancy and transcriptional landscape of a clinical isolate of Vibrio cholerae. | bioRxiv | 2024 | 38260642 | PubTator, text mining | PubMed |
| [Advances on BTB protein ubiquitination mediated plant development and stress response]. | Sheng Wu Gong Cheng Xue Bao | 2024 | 38258632 | PubTator, text mining | PubMed |
| Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis. | JHEP Rep | 2024 | 38192535 | PubTator, text mining | PubMed |
| Maternal and neonatal outcomes of intrahepatic cholestasis of pregnancy after in vitro fertilization. | BMC Pregnancy Childbirth | 2024 | 38191339 | PubTator, text mining | PubMed |
| Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment. | NPJ Breast Cancer | 2024 | 38182588 | PubTator, text mining | PubMed |
| Identification of a Notch transcriptomic signature for breast cancer. | Breast Cancer Res | 2024 | 38172915 | PubTator, text mining | PubMed |
| Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer. | J Cancer | 2024 | 38169571 | PubTator, text mining | PubMed |
| cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer. | NPJ Breast Cancer | 2024 | 38167507 | PubTator, text mining | PubMed |
| MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer. | Int J Biol Sci | 2024 | 38164185 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis unveils the significant prognostic value and potential role in immune microenvironment modulation of TRIB3. | Comput Struct Biotechnol J | 2024 | 38161736 | PubTator, text mining | PubMed |
| The amino acid transporter SLC7A11 expression in breast cancer. | Cancer Biol Ther | 2024 | 38073087 | PubTator, text mining | PubMed |
| Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer. | Transl Oncol | 2024 | 37897832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=6